Literature DB >> 11746857

Chemistry and pharmacology of the Citrus bioflavonoid hesperidin.

A Garg1, S Garg, L J Zaneveld, A K Singla.   

Abstract

Hesperidin, a bioflavonoid, is an abundant and inexpensive by-product of Citrus cultivation. A deficiency of this substance in the diet has been linked with abnormal capillary leakiness as well as pain in the extremities causing aches, weakness and night leg cramps. No signs of toxicity have been observed with the normal intake of hesperidin or related compounds. Both hesperidin and its aglycone hesperetin have been reported to possess a wide range of pharmacological properties. This paper reviews various aspects of hesperidin and its related compounds, including their occurrence, physical and chemical properties, analysis, pharmacokinetics, safety and toxicity and the marketed products available. A special emphasis has been laid on the pharmacological properties and medicinal uses of these compounds. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746857     DOI: 10.1002/ptr.1074

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  113 in total

1.  Passive asymmetric transport of hesperetin across isolated rabbit cornea.

Authors:  Ramesh Srirangam; Soumyajit Majumdar
Journal:  Int J Pharm       Date:  2010-05-09       Impact factor: 5.875

2.  Hesperidin suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model.

Authors:  Dajun Wei; Xinxin Ci; Xiao Chu; Miaomiao Wei; Shucheng Hua; Xuming Deng
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

3.  Citrus flavonoids in fruit and traditional Chinese medicinal food ingredients in China.

Authors:  Yanhua Lu; Chongwei Zhang; Peter Bucheli; Dongzhi Wei
Journal:  Plant Foods Hum Nutr       Date:  2006-07-01       Impact factor: 3.921

4.  Protective effects of citrus based mixture drinks (CBMDs) on oxidative stress and restraint stress.

Authors:  MyoungLae Cho; Dan-Bi Kim; Gi-Hae Shin; Jae-Min Kim; Yoonhee Seo; Soo Young Choe; Ju Hyun Cho; Young-Cheul Kim; Jin-Ha Lee; Ok-Hwan Lee
Journal:  Food Sci Biotechnol       Date:  2018-05-23       Impact factor: 2.391

5.  Comparative study of the vasorelaxant activity, superoxide-scavenging ability and cyclic nucleotide phosphodiesterase-inhibitory effects of hesperetin and hesperidin.

Authors:  Francisco Orallo; Ezequiel Alvarez; Hélène Basaran; Claire Lugnier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-17       Impact factor: 3.000

6.  Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes.

Authors:  Huan Wang; Hong-Fei Wang; Hao Zhang; Chen Wang; Yu-Fang Chen; Rong Ma; Ji-Zhou Xiang; Xin-Ling Du; Qiang Tang
Journal:  Acta Pharmacol Sin       Date:  2016-10-03       Impact factor: 6.150

7.  The amendatory effect of hesperidin and thymol in allergic rhinitis: an ovalbumin-induced rat model.

Authors:  Korhan Kilic; Muhammed Sedat Sakat; Serkan Yildirim; Fatih Mehmet Kandemir; Mustafa Sitki Gozeler; Muhammed Bahaeddin Dortbudak; Sefa Kucukler
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-11-28       Impact factor: 2.503

8.  Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: a natural bioflavonoid.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  Pharm Res       Date:  2008-09-23       Impact factor: 4.200

9.  Single Dose Oral and Intravenous Pharmacokinetics and Tissue Distribution of a Novel Hesperetin Derivative MTBH in Rats.

Authors:  Chenlin Shen; Zhengyue Qian; Ruonan Chen; Xiaoming Meng; Tingting Hu; Zhaolin Chen; Yangyang Li; Cheng Huang; Chaojie Hu; Jun Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-12       Impact factor: 2.441

10.  Synthesis, cytotoxic activity, and DNA binding properties of copper (II) complexes with hesperetin, naringenin, and apigenin.

Authors:  Mingxiong Tan; Jinchan Zhu; Yingming Pan; Zhenfeng Chen; Hong Liang; Huagang Liu; Hengshan Wang
Journal:  Bioinorg Chem Appl       Date:  2009-10-08       Impact factor: 7.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.